Is Vilin Bio Med Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Vilin Bio Med Ltd (VILINBIO.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Vilin Bio Med Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vilin Bio Med Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Vilin Bio Med Ltd?

Muslim investors may consider investing in Vilin Bio Med Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vilin Bio Med Ltd classified as HALAL?

Musaffa determines the Shariah status of Vilin Bio Med Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vilin Bio Med Ltd updated?

The Shariah compliance status of Vilin Bio Med Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vilin Bio Med Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vilin Bio Med Ltd?

You can check the latest Shariah compliance status of Vilin Bio Med Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Vilin Bio Med Ltd VILINBIO.NS

₹49.40 ₹5.00 (9.19%) 1D

Last Updated: May 12, 12:00 AM·NSE

VILINBIO.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 02, 2026

Report Source: 2026 2nd Quarter Report

Vilin Bio Med Ltd. Stock Analysis VILINBIO.NS

India Health Care Nano Cap Report: Q2, 2026

Vilin Bio Med Ltd. engages in the business of manufacturing pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2023-06-30. The firm is engaged in the manufacturing of pharmaceutical formulations, such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules and nutritional food supplements. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotic drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system and anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals and amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) tablets, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, ciprofloxacin, fluocinolone acetonide and others.

Key Statistics of Vilin Bio Med Ltd (VILINBIO.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹49.40₹54.40

Today's Open

₹54.40

Volume

36.00K

P/E Ratio (TTM)

2,057.10

52 Week Range

₹18.95₹54.40

Market Cap

568.46M

Avg. Volume

18.67K

Dividend Yield

Financial Metrics & Statements of Vilin Bio Med Ltd (VILINBIO.NS)

FAQ's for Vilin Bio Med Ltd (VILINBIO.NS)

According to Musaffa’s Shariah screening methodology, Vilin Bio Med Ltd (VILINBIO.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.